E. M. I. Williams

2.0k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

E. M. I. Williams is a scholar working on Clinical Psychology, Oncology and Epidemiology. According to data from OpenAlex, E. M. I. Williams has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Psychology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in E. M. I. Williams's work include Palliative Care and End-of-Life Issues (3 papers), Autopsy Techniques and Outcomes (3 papers) and Grief, Bereavement, and Mental Health (3 papers). E. M. I. Williams is often cited by papers focused on Palliative Care and End-of-Life Issues (3 papers), Autopsy Techniques and Outcomes (3 papers) and Grief, Bereavement, and Mental Health (3 papers). E. M. I. Williams collaborates with scholars based in United Kingdom, United States and Estonia. E. M. I. Williams's co-authors include Gillian Maudsley, John Ellershaw, Abeer M. Shaaban, Christopher S. Foster, Christopher R. West, C Jarvis, J P Sloane, M Hartley, James D. Evans and Jiten Vora and has published in prestigious journals such as The Lancet, Gut and British Journal of Cancer.

In The Last Decade

E. M. I. Williams

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE CLASSIFICATION OF CARCINOID TUMOURS

1963 660 citations E. M. I. Williams The Lancet profile →

Peers

Countries citing papers authored by E. M. I. Williams

Since Specialization

Citations

This map shows the geographic impact of E. M. I. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. I. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. I. Williams more than expected).

Fields of papers citing papers by E. M. I. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. I. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. I. Williams. The network helps show where E. M. I. Williams may publish in the future.

Co-authorship network of co-authors of E. M. I. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. I. Williams. A scholar is included among the top collaborators of E. M. I. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. I. Williams. E. M. I. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Does the ‘Liverpool Care Pathway’ facilitate an improvement in quality of care for dying cancer patients? 2013 ·British Journal of Cancer ·Catriona R Mayland, E. M. I. Williams, Julia Addington‐Hall, Trevor F. Cox, John Ellershaw	25
2	How well do current instruments using bereaved relatives’ views evaluate care for dying patients? 2008 ·Palliative Medicine ·(unknown), E. M. I. Williams, John Ellershaw	29
3	Defining the Difficult ERCP. Performance of the ASGE (Modified Schutz) Scoring System in a Prospectively Studied Cohort of 5264 Procedures 2006 ·Gastrointestinal Endoscopy ·E. M. I. Williams	4
4	Prognostic value of morphology and hormone receptor status in breast cancer – a population-based study 2004 ·British Journal of Cancer ·Claudia Allemani, Milena Sant, Franco Berrino, Tiiu Aareleid, Gilles Chaplain, J.W.W. Coebergh, Marc Colonna, Paolo Contiero, Arlette Danzon, Massimo Federico, Lorenzo Gafà, Pascale Grosclaude, Guy Hédelin, Josette Macé-Lesec’h, Carmen Martínez García, Euǵenio Paci, N Raverdy, Brigitte Trétarre, E. M. I. Williams	37
5	Surgery for midgut carcinoid. 2003 ·Endocrine Related Cancer ·Robert Sutton, H Doran, E. M. I. Williams, Jiten Vora, Sobhan Vinjamuri, James D. Evans, F C Campbell, Michael Raraty, Paula Ghaneh, M Hartley, G.J. Poston, John P. Neoptolemos	69
6	Histopathologic Types of Benign Breast Lesions and the Risk of Breast Cancer 2002 ·The American Journal of Surgical Pathology ·Abeer M. Shaaban, J P Sloane, Christopher R. West, (unknown), C Jarvis, E. M. I. Williams, Christopher S. Foster	90
7	Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry 1997 ·British Journal of Cancer ·(unknown), E. M. I. Williams	27
8	'Inaccuracy' in death certification - where are we now? 1996 ·Journal of Public Health ·Gillian Maudsley, E. M. I. Williams	139
9	Asthma deaths in Mersey Region 1989–1990 1995 ·Journal of Public Health ·Matthew C. Somerville, E. M. I. Williams, M Pearson	8
10	Portal hypertension 1993 ·Gut ·(unknown), E. M. I. Williams, (unknown), (unknown), (unknown), R. A. Shields	4
11	Death certification by House Officers and General Practitioners — practice and performance 1993 ·Journal of Public Health ·Gillian Maudsley, E. M. I. Williams	61
12	Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group. 1990 ·BMJ ·Andreas Laupacis, E. M. I. Williams, Lisa Jones, (unknown), Klim McPherson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	335
13	THE CLASSIFICATION OF CARCINOID TUMOURS breakdown → 1963 ·The Lancet ·E. M. I. Williams	660

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact